CHU Ambroise Paré

Mons, Hainaut 7000

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Renal Cell, Gastric Cancer, Gastroesophageal Junction Cancer

Studies at this site

• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed